000 01073 a2200277 4500
005 20250516064828.0
264 0 _c20130712
008 201307s 0 0 eng d
022 _a1433-8726
024 7 _a10.1007/s00345-011-0798-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYates, David R
245 0 0 _aComparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response.
_h[electronic resource]
260 _bWorld journal of urology
_cFeb 2013
300 _a117-25 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aDisease-Free Survival
650 0 4 _aHumans
650 0 4 _aPalliative Care
_xmethods
650 0 4 _aTreatment Outcome
650 0 4 _aUrogenital Neoplasms
_xdrug therapy
700 1 _aRouprĂȘt, Morgan
773 0 _tWorld journal of urology
_gvol. 31
_gno. 1
_gp. 117-25
856 4 0 _uhttps://doi.org/10.1007/s00345-011-0798-5
_zAvailable from publisher's website
999 _c21335574
_d21335574